• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Major European congress focuses on contrast agents

Article

The European Conference on Contrast Agent Science will take place in Mons, Belgium, from 19 to 21 May 2010.

The European Conference on Contrast Agent Science will take place in Mons, Belgium, from 19 to 21 May 2010.

Since 1988, the European MR Forum (EMRF) has arranged a series of biannual conferences focused on recent developments in image contrast enhancement by agents or tracers. The purpose of these meetings is to allow those interested in the field to get together to present their research in a setting that fosters discussion, collaboration, and advancement in the field. From the beginning, this group has been composed of both university scientists and representatives from industry.

The conference is organized on the principle of formal scientific exchange during the academic sessions and informal interaction during the rest of the day. Over the years, this has led to the development of new projects and products, often collaborative ones, between industry and academics or between universities. As always, the traditional mood of friendly and open exchange in Mons between the industrial and academic communities will be preserved.

EMRF's conferences are ongoing projects. Their continuity and success depend not only on the intellectual interest, contribution, and support of academics and commercial researchers in the field, as well as on financial support from the research branches of industry, but they also require the attention and input of scientists, radiologists, trainees, and other researchers who use, and improve, contrast agents of all kinds.

This is the first time since 1988 that EMRF requires abstract submissions. Abstracts should reach the scientific committee by 20 March 2010 (extended deadline). They should be attached to the submitter's conference registration.

For more information, please visit: EMRF Online.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.